Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
3.970
-0.250 (-5.92%)
At close: May 29, 2026, 4:00 PM EDT
4.200
+0.230 (5.79%)
After-hours: May 29, 2026, 7:54 PM EDT
Myriad Genetics Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Myriad Genetics stock has a consensus rating of "Hold" and an average price target of $6.25. The average 1-year stock price forecast is 57.43% higher than the current stock price, while the lowest is $4.00 (+0.76%) and the highest is $10 (+151.89%).
Price Target: $6.25 (+57.43%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Myriad Genetics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 7 | 7 | 7 | 7 | 7 | 6 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 12 | 12 | 12 | 12 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $8.5 | Buy | Maintains | $8.5 | +114.11% | May 12, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Maintains n/a | Sell | Maintains | n/a | n/a | May 7, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 7, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $6 → $5.5 | Hold | Maintains | $6 → $5.5 | +38.54% | May 6, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $10 | Buy | Reiterates | $10 | +151.89% | May 6, 2026 |
Financial Forecast
Revenue This Year
880.78M
from 824.50M
Increased by 6.83%
Revenue Next Year
933.14M
from 880.78M
Increased by 5.94%
EPS This Year
0.05
from -3.95
EPS Next Year
0.16
from 0.05
Increased by 220.80%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 914.0M | 990.4M | |||
| Avg | 880.8M | 933.1M | |||
| Low | 842.0M | 876.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 10.9% | 12.4% | |||
| Avg | 6.8% | 5.9% | |||
| Low | 2.1% | -0.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.09 | 0.35 | |||
| Avg | 0.05 | 0.16 | |||
| Low | -0.06 | 0.04 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 579.4% | |||
| Avg | - | 220.8% | |||
| Low | - | -23.1% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.